Low-Molecular-Weight Heparins in Prophylaxis and Therapy of Thromboembolic Diseases (Fundamental and Clinical Cardiology)

Detailing the basic and clinical science of low-molecular-weight heparins, this valuable reference assesses the efficacy and safety of using this new class of antithrombotic agents in the prevention and treatment of venous thromboembolism–explaining the advantages of low-molecular-weight heparins, as compared with regular, unfractionated heparins. Containing the authoritative contributions of over 25 specialists from Europe and North America, Low-Molecular-Weight Heparins in Prophylaxis and Therapy of Thromboembolic Diseases investigates the pharmacology, mechanisms of action, and laboratory monitoring of low-molecular-weight heparins offers a first appraisal of the use of low-molecular-weight heparins in the treatment of established venous thromboembolism presents systematic overviews of the use of low-molecular-weight heparins in the prevention of venous thromboembolism following general, neuro-, and orthopedic surgery, and in immobilized medical patients, as well as in extracorporeal circuits delineates the interactions of low-molecular-weight heparin compounds with endothelial cells, blood platelets, the fibrinolytic system, and the proliferation of smooth muscle tissue and more!